TY  - JOUR
AU  - Mensa Vendrell, Mireia
AU  - Tasias Pitarch, Maria
AU  - Salavert Lletí, Miguel
AU  - Calabuig Muñoz, Eva
AU  - Morata Ruiz, Laura
AU  - Castells Lao, Genís
AU  - López Suñé, Ester
AU  - Mensa Pueyo, Jose
AU  - Oltra Sempere, Maria Rosa
AU  - Pedro-Botet Montoya, Maria-Luisa
AU  - Isernia, Valentina
AU  - Reynaga Sosa, Esteban Alberto
AU  - Moreno Nuñez, Leonor
AU  - Pasquau Liaño, Juan
AU  - Sequera Arquelladas, Sergio
AU  - Yuste Ara, José Ramón
AU  - Soriano Viladomiu, Alex
PY  - 2020
DO  - 10.1128/AAC.00356-20
UR  - http://hdl.handle.net/10668/15398
T2  - Antimicrobial agents and chemotherapy
AB  - Tedizolid has demonstrated its efficacy and safety in clinical trials; however, data concerning its tolerability in long-term treatments are scarce. The aim of the study was to assess the indications and to describe the long-term safety profile of...
LA  - en
KW  - adverse events
KW  - safety
KW  - tedizolid
KW  - tolerability
KW  - Anti-Bacterial Agents
KW  - Humans
KW  - Organophosphates
KW  - Oxazoles
KW  - Oxazolidinones
KW  - Retrospective Studies
KW  - Skin Diseases, Bacterial
KW  - Tetrazoles
TI  - Safety and Tolerability of More than Six Days of Tedizolid Treatment.
TY  - research article
VL  - 64
ER  -